LINC00665: An Emerging Biomarker for Cancer Diagnostics and Therapeutics
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LINC00665: An Emerging Biomarker for Cancer Diagnostics and Therapeutics
Authors
Keywords
-
Journal
Cells
Volume 11, Issue 9, Pages 1540
Publisher
MDPI AG
Online
2022-05-04
DOI
10.3390/cells11091540
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metastasis and MAPK Pathways
- (2022) Mateusz Kciuk et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- LINC00665 enhances tumorigenicity of endometrial carcinoma by interacting with high mobility group AT-hook 1
- (2021) Yixuan Cai et al. Cancer Cell International
- NF-κB 1-induced LINC00665 regulates inflammation and apoptosis of neurons caused by spinal cord injury by targeting miR-34a-5p
- (2021) Qilong Deng et al. NEUROLOGICAL RESEARCH
- LINC00665 functions as a competitive endogenous RNA to regulate AGTR1 expression by sponging miR‑34a‑5p in glioma
- (2021) Yongyue Dai et al. ONCOLOGY REPORTS
- Long non-coding RNA LINC00665 promotes gemcitabine resistance of Cholangiocarcinoma cells via regulating EMT and stemness properties through miR-424-5p/BCL9L axis
- (2021) Min Lu et al. Cell Death & Disease
- Long non-coding RNA linc00665 inhibits CDKN1C expression by binding to EZH2 and affects cisplatin sensitivity of NSCLC cells
- (2021) Daolu Yang et al. Molecular Therapy-Nucleic Acids
- Identification of LINC00665-miR-let-7b-CCNA2 competing endogenous RNA network associated with prognosis of lung adenocarcinoma
- (2021) Yusheng Huang et al. Scientific Reports
- LINC00665 promotes the progression of acute myeloid leukemia by regulating the miR-4458/DOCK1 pathway
- (2021) Xiaoyu Yang et al. Scientific Reports
- LINC00665 Stimulates Breast Cancer Progression via Regulating miR-551b-5p
- (2021) Liqiang Qi et al. Cancer Management and Research
- Linc00665 Can Predict the Response to Cisplatin-Paclitaxel Neoadjuvant Chemotherapy for Breast Cancer Patients
- (2021) Huijuan Dai et al. Frontiers in Oncology
- Long intergenic noncoding RNA 00665 promotes proliferation and inhibits apoptosis in colorectal cancer by regulating miR-126-5p
- (2021) Chang-Liang Wu et al. Aging-US
- LINC00665/miR-379-5p/GRP78 regulates cisplatin sensitivity in gastric cancer by modulating endoplasmic reticulum stress
- (2021) Chao Yue et al. CYTOTECHNOLOGY
- Up-Regulation of LINC00665 Facilitates the Malignant Progression of Prostate Cancer by Epigenetically Silencing KLF2 Through EZH2 and LSD1
- (2021) Peng Xue et al. Frontiers in Oncology
- Downregulation of LINC00665 suppresses the progression of lung adenocarcinoma via regulating miR-181c-5p/ZIC2 axis
- (2021) Wei Wei et al. Aging-US
- LINC00665 activates Wnt/β-catenin signaling pathway to facilitate tumor progression of colorectal cancer via upregulating CTNNB1
- (2021) Ting Han et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- LINC00665 promotes cell proliferation, invasion, and metastasis by activating the TGF-β pathway in gastric cancer
- (2021) Xiaohu Zhang et al. PATHOLOGY RESEARCH AND PRACTICE
- LINC00665 promotes the viability, migration and invasion of T cell acute lymphoblastic leukemia cells by targeting miR-101 via modulating PI3K/Akt pathway
- (2021) Muhebaier abuduer et al. TISSUE & CELL
- LINC00665 Facilitates the Malignant Processes of Osteosarcoma by Increasing the RAP1B Expression via Sponging miR-708 and miR-142-5p
- (2021) Limin Wang et al. Analytical Cellular Pathology
- The lncRNAs LINC00261 and LINC00665 are upregulated in long-term prostate cancer adaptation after radiotherapy
- (2021) Iris Eke et al. Molecular Therapy-Nucleic Acids
- The Long Noncoding RNA LINC00665 Facilitates c-Myc Transcriptional Activity via the miR-195-5p MYCBP Axis to Promote Progression of Lung Adenocarcinoma
- (2021) Anpeng Wang et al. Frontiers in Oncology
- Non-magnetic shell coating of magnetic nanoparticles as key factor of toxicity for cancer cells in a low frequency alternating magnetic field
- (2021) A.R. Iliasov et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Inflammation‐induced LINC00665 increases the malignancy through activating PKR/NF‐κB pathway in hepatocellular carcinoma
- (2020) Jie Ding et al. HEPATOLOGY
- LINC00665 promotes breast cancer progression through regulation of the miR-379-5p/LIN28B axis
- (2020) Wei Ji et al. Cell Death & Disease
- LncRNA LINC00665 Promotes Prostate Cancer Progression via miR-1224-5p/SND1 Axis
- (2020) Wei Chen et al. OncoTargets and Therapy
- Integrated analysis of lymphocyte infiltration-associated lncRNA for ovarian cancer via TCGA, GTEx and GEO datasets
- (2020) Meijing Wu et al. PeerJ
- Long non-coding RNA linc00665 interacts with YB-1 and promotes angiogenesis in lung adenocarcinoma
- (2020) Zhuangzhuang Cong et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Downregulation of LINC00665 confers decreased cell proliferation and invasion via the miR-138-5p/E2F3 signaling pathway in NSCLC
- (2020) Huaqi Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- LINC00665 Promotes the Progression of Multiple Myeloma by Adsorbing miR-214-3p and Positively Regulating the Expression of PSMD10 and ASF1B
- (2020) Chong Wang et al. OncoTargets and Therapy
- LINC00665/miR-9-5p/ATF1 is a novel axis involved in the progression of colorectal cancer
- (2020) Xuhong Zhao et al. Human Cell
- lncRNA LINC00665 Stabilized by TAF15 Impeded the Malignant Biological Behaviors of Glioma Cells via STAU1-Mediated mRNA Degradation
- (2020) Xuelei Ruan et al. Molecular Therapy-Nucleic Acids
- Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1
- (2020) Minhao Lv et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Long non‐coding RNA LINC00665 promotes melanoma cell growth and migration via regulating the miR‐224‐5p/VMA21 axis
- (2020) Xiaonan Wang et al. EXPERIMENTAL DERMATOLOGY
- Long non-coding RNA linc00665 promotes lung adenocarcinoma progression and functions as ceRNA to regulate AKR1B10-ERK signaling by sponging miR-98
- (2019) Zhuangzhuang Cong et al. Cell Death & Disease
- LINC00665 Induces Acquired Resistance to Gefitinib through Recruiting EZH2 and Activating PI3K/AKT Pathway in NSCLC
- (2019) Xinyin Liu et al. Molecular Therapy-Nucleic Acids
- Long non-coding RNA LINC00665 gastric cancer tumorigenesis by regulation miR-149-3p/RNF2 axis
- (2019) Hongyang Qi et al. OncoTargets and Therapy
- Micropeptide CIP 2A‐ BP encoded by LINC 00665 inhibits triple‐negative breast cancer progression
- (2019) Binbin Guo et al. EMBO JOURNAL
- LINC00665 induces gastric cancer progression through activating Wnt signaling pathway
- (2019) Bo Yang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction
- (2018) Dong-Yue Wen et al. MEDICAL SCIENCE MONITOR
- AKR1B10 promotes breast cancer cell migration and invasion via activation of ERK signaling
- (2017) Jia Li et al. Oncotarget
- Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance
- (2015) P Khongkow et al. ONCOGENE
- The multilayered complexity of ceRNA crosstalk and competition
- (2014) Yvonne Tay et al. NATURE
- Targeting PI3K/Akt/mTOR Signaling in Cancer
- (2014) Camillo Porta et al. Frontiers in Oncology
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
- (2011) Leonardo Salmena et al. CELL
- Molecular Mechanisms of Long Noncoding RNAs
- (2011) Kevin C. Wang et al. MOLECULAR CELL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started